EUVIMEDEUVIMED entdecken
Crossref

Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis

Marcello Persico, Valerio Rosato, Andrea Aglitti, Davide Precone, Mariano Corrado, Antonio De Luna, Filomena Morisco, Silvia Camera, Alessandro Federico, Marcello Dallio, Ernesto Claar, Nicola Caporaso und 1 weitere

Antiviral Therapy · 2018-02 · 23 (2) · 129-138

DOI: 10.3851/imp3186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Therapy, online erschienen am 01.02.2017. Verfasst von Marcello Persico und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine and Hepatology Division, Department of Medicine and Surgery, University of Salerno, Salerno, Italy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Direct antiviral agents (DAA) demonstrated high efficacy among HCV-infected patients in registered trials. Nevertheless, the impact of these therapies on liver stiffness measurement (LSM) and liver functionality in ‘real-life’ is not well-known. The aim of the present study was to evaluate the sustained virological response (SVR) impact on LSM and clinical parameters of DAA-therapy on a real-life population of HCV patients with F3/F4 fibrosis.

Methods

A total of 749 HCV genotype 1–4 patients with F3/F4 hepatitis undergoing antiviral therapy were consecutively enrolled in four centres of hepatology in Italy. Clinical, biochemical and imaging data were collected at the baseline (T0), at the end of treatment (EoT) and after 12 weeks (SVR12).

Results

Out of 749 patients, 69.7% were F4 and 30.3% were F3. SVR12 was reached in 97.5%. LSM significantly decreased from T0 to EoT ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsBiomarkersDrug Therapy, CombinationElasticity Imaging TechniquesFemaleGenotypeHepacivirusHepatitis C, ChronicHumansHypertension, PortalLiver CirrhosisMaleRecurrenceSeverity of Illness IndexSustained Virologic Response

Substanzen

Antiviral AgentsBiomarkers

Autor:innen und Institutionen

  • Internal Medicine and Hepatology Division, Department of Medicine and Surgery, University of Salerno, Salerno, Italy.
  • Internal Medicine and Hepatology Department, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Internal Medicine Department, Martiri di Villa Malta Hospital, Sarno, Salerno, Italy.
  • Infectious Diseases Department, Umberto I Hospital, Nocera Inferiore, Salerno, Italy.
  • Drug Addictions Unit, ASL Salerno DS65, Salerno, Italy.
  • Gastroenterology Unit, Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Zitieren

APA

Persico, M., Rosato, V., Aglitti, A., Precone, D., Corrado, M., De Luna, A., Morisco, F., Camera, S., Federico, A., Dallio, M., Claar, E., Caporaso, N., & Masarone, M. (2018). Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis. Antiviral Therapy, 23(2), 129-138. https://doi.org/10.3851/imp3186

Vancouver

Persico M, Rosato V, Aglitti A, Precone D, Corrado M, De Luna A, et al. Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis. Antiviral Therapy. 2018;23(2):129-138. doi:10.3851/imp3186

BibTeX
@article{Persico2018,
  author = {Persico, Marcello and Rosato, Valerio and Aglitti, Andrea and Precone, Davide and Corrado, Mariano and De Luna, Antonio and Morisco, Filomena and Camera, Silvia and Federico, Alessandro and Dallio, Marcello and Claar, Ernesto and Caporaso, Nicola and Masarone, Mario},
  title = {Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis},
  journal = {Antiviral Therapy},
  year = {2018},
  volume = {23},
  number = {2},
  pages = {129--138},
  doi = {10.3851/imp3186}
}
Kostenlos starten →